Neurogene Inc. (NGNE)
NASDAQ·Healthcare·Biotechnology
$30.85
-8.33%
Mkt Cap $507.10M
Analyst Ratings
Buy
5
Hold
0
Sell
0
Price Target (15 analysts)
$69.67
Range $69.00 – $70.00
Implied Upside
+125.8%
Consensus $69.67 vs current $30.85
NASDAQ·Healthcare·Biotechnology
$30.85
-8.33%
Mkt Cap $507.10M
Buy
5
Hold
0
Sell
0
Price Target (15 analysts)
$69.67
Range $69.00 – $70.00
+125.8%
Consensus $69.67 vs current $30.85